Justin Loke

Medicine & Life Sciences

1. Acute Myeloid Leukemia 100%
2. Allogeneic Cells 25%
3. Stem Cell Transplantation 22%
4. Transplants 21%
5. Leukemia 18%
6. Chromatin 15%
7. Recurrence 12%
8. Transcription Factors 12%
9. Gemtuzumab 11%
10. romidepsin 11%
11. Chimerism 11%
12. Mutation 11%
13. Gene Regulatory Networks 10%
14. Cytogenetics 10%
15. GATA2 Deficiency 10%
16. Azacitidine 9%
17. Epigenomics 9%
18. T-Lymphocytes 9%
19. Glycopeptides 9%
20. Unrelated Donors 9%
21. Allografts 9%
22. Tissue Donors 7%
23. Arginine 7%
24. HLA Antigens 7%
25. Drug Therapy 7%
26. Siblings 6%
27. Survival 6%
28. BCT-100 6%
29. Transplantation 6%
30. Anti-Idiotypic Antibodies 6%
31. Epigenome 6%
32. Bone Marrow 5%
33. Vaccination 5%
34. Genes 5%
35. Meta-Analysis 5%
36. fludarabine 5%
37. Systematic Reviews 5%
38. Confidence Intervals 5%
39. Therapeutics 5%
40. Maintenance 5%
41. Stem Cells 5%